T. Rowe Price Associates’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59B | Buy |
|
|||||
|
2025
Q1 | $1.45B | Sell |
|
|||||
|
2024
Q4 | $1.92B | Buy |
|
|||||
|
2024
Q3 | $962M | Buy |
|
|||||
|
2024
Q2 | $508M | Sell |
|
|||||
|
2024
Q1 | $634M | Sell |
|
|||||
|
2023
Q4 | $761M | Buy |
|
|||||
|
2023
Q3 | $514M | Buy |
|
|||||
|
2023
Q2 | $235M | Sell |
|
|||||
|
2023
Q1 | $266M | Sell |
|
|||||
|
2022
Q4 | $399M | Sell |
|
|||||
|
2022
Q3 | $435M | Sell |
|
|||||
|
2022
Q2 | $899M | Sell |
|
|||||
|
2022
Q1 | $1.86B | Buy |
|
|||||
|
2021
Q4 | $834M | Buy |
|
|||||
|
2021
Q3 | $672M | Sell |
|
|||||
|
2021
Q2 | $743M | Buy |
|
|||||
|
2021
Q1 | $625M | Sell |
|
|||||
|
2020
Q4 | $863M | Sell |
|
|||||
|
2020
Q3 | $1.17B | Sell |
|
|||||
|
2020
Q2 | $1.25B | Buy |
|
|||||
|
2020
Q1 | $988M | Buy |
|
|||||
|
2019
Q4 | $883M | Sell |
|
|||||
|
2019
Q3 | $936M | Buy |
|
|||||
|
2019
Q2 | $402M | Sell |
|
|||||
|
2019
Q1 | $364M | Buy |
|
|||||
|
2018
Q4 | $290M | Sell |
|
|||||
|
2018
Q3 | $360M | Buy |
|
|||||
|
2018
Q2 | $273M | Buy |
|
|||||
|
2018
Q1 | $218M | Buy |
|
|||||
|
2017
Q4 | $136M | Sell |
|
|||||
|
2017
Q3 | $136M | Sell |
|
|||||
|
2017
Q2 | $294M | Sell |
|
|||||
|
2017
Q1 | $395M | Sell |
|
|||||
|
2016
Q4 | $575M | Buy |
|
|||||
|
2016
Q3 | $515M | Sell |
|
|||||
|
2016
Q2 | $512M | Buy |
|
|||||
|
2016
Q1 | $459M | Buy |
|
|||||
|
2015
Q4 | $186M | Sell |
|
|||||
|
2015
Q3 | $209M | Buy |
|
|||||
|
2015
Q2 | $194M | Buy |
|
|||||
|
2015
Q1 | $169M | Buy |
|
|||||
|
2014
Q4 | $149M | Buy |
|
|||||
|
2014
Q3 | $123M | Buy |
|
|||||
|
2014
Q2 | $95.9M | Sell |
|
|||||
|
2014
Q1 | $119M | Buy |
|
|||||
|
2013
Q4 | $119M | Sell |
|
|||||
|
2013
Q3 | $149M | Buy |
|
|||||
|
2013
Q2 | $150M | Buy |
|